Skip to main content
Clinical Trials/NCT02977559
NCT02977559
Unknown
Not Applicable

A Comparative Randomized Prospective Study Between the New Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients

Bnai Zion Medical Center0 sites60 target enrollmentMarch 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adverse Anesthesia Outcome
Sponsor
Bnai Zion Medical Center
Enrollment
60
Primary Endpoint
Leak pressure measure in cm H2O
Last Updated
9 years ago

Overview

Brief Summary

The study compared the Laryngeal Tube Suction Disposable (LTS-D) with the Disposable Laryngeal Mask Ambu® AuraGain™ (DLMA AG) during general anesthesia in pediatric patients.

The investigators hypothesized that the LTS-D and the DLMA AG performed similarly during mechanical ventilation despite differences in their structural design.

Detailed Description

The Laryngeal Tube Suction-Disposable (LTS-D, (VBM Medizintechnik GmbH, Sulz, Germany), is a second generation single-use supraglottic airway devices (SADs) with gastric access, for airway management in spontaneously and mechanically ventilated patients undergoing general anesthesia. The AuraGain is a second generation laryngeal mask, satisfying airway management needs by integrating gastric access and ventilation capability in an anatomically curved single-use device that facilitates rapid establishment of a safe airway. The two devices have now pediatric sizes. To date, there is no published data comparing the LTS-D and the DLMA AG during mechanical ventilation in pediatric patients. The investigators hypothesized that the LTS-D and the DLMA AG perform similarly during mechanical ventilation despite differences in their structural design. The chief aim of this prospective randomized study was to compare the LTS-D and the DLMA AG with respect to: 1. time to achieve an effective airway, 2. ease of insertion, 3. need for interventions to achieve an effective airway, 4. cuff seal (leak) pressure at an intracuff pressure of 60 cm H2O, 5. ventilatory variables during mechanical ventilation, 6. fiberoptic score, 7. gastric tube insertion and 8. adverse perioperative events.

Registry
clinicaltrials.gov
Start Date
March 2017
End Date
September 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

LUIS.GAITINI

medical doctor

Bnai Zion Medical Center

Eligibility Criteria

Inclusion Criteria

  • Pediatric patients, American Society of Anesthesiologist (ASA) physical status I and II weighing 30 to 10 kg, posted for abdominal surgery under general anesthesia.

Exclusion Criteria

  • Infants with active respiratory tract infection anticipated and known difficult airway, lung disease requiring high positive end expiratory pressure, and active gastrointestinal reflux will be excluded.

Outcomes

Primary Outcomes

Leak pressure measure in cm H2O

Time Frame: 60 seconds

Secondary Outcomes

  • Time to insertion a device in seconds(60 seconds)

Similar Trials